DOTA Conjugated JM#21 derivative 7, CAS 3033865-40-3

Description: DOTA-Conjugated JM#21 Derivative 7 (compound Ligand-7) is a CXCR4-targeting peptide derivative conjugated with DOTA, suitable for producing radioligands. Radiolabeled with 177Lu, this compound, referred to as 177Lu-DOTA, demonstrates superior CXCR4 tumor targeting capabilities. In vitro biodistribution studies of 177Lu-DOTA indicate minimal uptake in non-target organs, with the exception of the kidneys.

CAS Number: 3033865-40-3

Formula: C66H114N22O16

Molecular Weight: 1471,75

• Artikelnummer: TGMTP2658-50mg
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: TP2658-50mg
• Verpackungseinheit: 50 mg
• Mengeneinheit: STK